Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Five Prime Therapeutics Inc (FPRX)

NASDAQ
Currency in USD
Disclaimer
38.00
0.00(0.00%)
Closed

FPRX Comments

I's going back to 5.
will it go back to 23?
when the dilution is over, usually take some days. When Bio sector come back for gaining, it will follow.
down trend, I got 10 Puts, may be oversold on next week. Time to fill its gaps.
5,000,000 shares of its common stock in an underwritten public offering in the offering a 30-day option to purchase up to an additional 750,000 shares of common stock offered in the public offering.
Article? Link ?
 offering price is $21 just posted today. Do your own DD. I will try to do but been busy today
 https://finance.yahoo.com/news/five-prime-announces-pricing-upsized-030000081.html
Nov 11th, my bad.
Offering was yesterday Nov 10th - 5 Mil = 750,000 shares within 30 days, dilution.
Time to drop, also offering can happen anytime by now.
Short or you’ll miss
yesterday i shorted and loss also bettertoshort @30
The news about the biontech vaccine is said to be false.
Link please?
ha ha they don't make vaccines petros...she is confused they have a medicine against cancer
Such a strong statement needs link and facts that is not the competition trying to under mine it
ok I bought 40 shares at 18....just for fun....ha ha
Den ksero KATHOLOU tin "DE HIRO". paizo me eurobank equities (den exein pre) KAI me tin exante (exei). Exo filo pou tin antiprosopeyei ellada an thes na sas fero se epafi.
Ypotheto itheles na peis "degiro". Episis me tin empeiria mou OS tora me agores poliseis pre / after. Den to synisto. 1 kerdizeis 10 xaneis. Se pre/after Mia megali paraggelia allazei dramatika tin timi.
Kali Ora simera itan oli I texnologia Kato sto pre KAI o nasdaq arnitikos. Sto anoigma gyrisan Ola ta xartia thetika. Exo poulisei etsi pre kai mou pige apo -3% pre se +7% synedriasi
if it drops at 20 i will buy some....this isnt pump and dump....they cured some cancer at clinical trials.....they have a press conference on a while
No, because hes not bought any yet im assuming haha
There you go George is below 19
Hope you will see what we are trying to tell you George. Not an ideal idea to “chase” the market. Also i saw your comment saying you bought it at 18 for fun? I highly reccommend not to buy a stock that you dont even know than just knowing theres so good news about it. Anyway, if you do earn some profit, good for you my friend, however, if you lose, im sorry and we have warned you. All the best buddy!
+390% PM
Another inflammation biotech, chart is looking good, getting lots of support. At $6.56.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.